BioPorto CEO announces new strategy

Peter Mørch Eriksen has two successful turnarounds on his CV - in the 90s for technology firm Brüel & Kjær, while the diagnostic division in Medtronic came under the care of the commercial expert later on. Now the time has come for BioPorto to make use of his expertise. Peter Mørch Eriksen has already decided on the overall steps for advancement of the distressed diagnostics company.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app